Nuklearmedizin 1976; 15(06): 297-299
DOI: 10.1055/s-0038-1624981
Originalarbeiten — Original Articles
Schattauer GmbH

Adrenal Scintigraphy with 131I-Adosterol

A. Kasperlik-Zaluska
1   From the Endocrinology Clinic (Head: Prof. Dr. W. Hartwig) Centre for Postgraduate Medical Education and the Nuclear Medicine Department, Institute of Oncology (Head: Doc. Dr. J. Szymendera) Warsaw
,
O. A. Chomicki
1   From the Endocrinology Clinic (Head: Prof. Dr. W. Hartwig) Centre for Postgraduate Medical Education and the Nuclear Medicine Department, Institute of Oncology (Head: Doc. Dr. J. Szymendera) Warsaw
,
W. Hartwig
1   From the Endocrinology Clinic (Head: Prof. Dr. W. Hartwig) Centre for Postgraduate Medical Education and the Nuclear Medicine Department, Institute of Oncology (Head: Doc. Dr. J. Szymendera) Warsaw
,
A. Mikołajków
1   From the Endocrinology Clinic (Head: Prof. Dr. W. Hartwig) Centre for Postgraduate Medical Education and the Nuclear Medicine Department, Institute of Oncology (Head: Doc. Dr. J. Szymendera) Warsaw
,
H. Siwicki
1   From the Endocrinology Clinic (Head: Prof. Dr. W. Hartwig) Centre for Postgraduate Medical Education and the Nuclear Medicine Department, Institute of Oncology (Head: Doc. Dr. J. Szymendera) Warsaw
› Author Affiliations
Further Information

Publication History

Received:14 September 1976

Publication Date:
10 January 2018 (online)

Preview

Summary

A new adrenal scanning agent, Adosterol (131I-6β-iodomethyl-19-norcholest-5(10)-en-3β-ol) has been evaluated in three female patients with hypercortic-ism. In one case, characterised by recurrent adrenocortical hyperactivity after bilateral adrenalectomy, a remnant of adrenal tissue was detected. In two other cases, the presence of an adrenal tumour could be excluded. The scan made on the 6th day after the administration of Adosterol was found to be superior in quality to that made on the 13th day.